InvestorsHub Logo
icon url

uncxman

06/06/05 1:36 PM

#27267 RE: geob #27266

geo just squashed the frog..again lol eom
icon url

mikenickels

06/06/05 2:58 PM

#27271 RE: geob #27266

Why would they be undergoing a clinical test
if they knew the product was completed to spec?
icon url

frogdreaming

06/06/05 11:52 PM

#27302 RE: geob #27266

Let's be clear about the difference between truth and conjecture.

Truth- Gabriel states it does not meet DNAP standards, is NOT ready for FDA.

Conjecture-

"They have a product that has a 96% success rate....

They, with the help of Moffit are under going a clinical study as we speak....

We can expect results and issuance to the FDA in or around 6 to 9 months....

DNAP's ONLY obstacle to date was the $1,000 per patient....

To perform the OVA test....

It seems that this obstacle has been overcome.....


96% is not supported, they have no verification data.

We have heard that the patients are being recruited by Gomez for the last two years. We have no evidence that the full clinical trial is underway yet.

There are many other potential obstacles besides the $1000 per patient. To suggest it is the only obstacle is a lie.

6 to 9 months is a pipe dream. It will take much longer than that AFTER the clinical trial is fully populated and begun.

regards,
frog